• GATES SVELA LE CARTE: L'ID DIGITALE COME ARMA FINALE CONTRO IL LIBERO PENSIERO
    Eccolo di nuovo. L'architetto della sorveglianza globale, il profeta autoproclamato delle emergenze sanitarie, il miliardario che sussurra all'orecchio dei governi avanza l'ennesimo tassello del suo progetto tecnocratico. Bill Gates – che non si nasconde più dietro veli di filantropia – articola con disarmante chiarezza la prossima fase: un sistema di identificazione digitale per soffocare quella che lui chiama "disinformazione".

    "Gli Stati Uniti rappresentano un caso complesso a causa del Primo Emendamento. Quali eccezioni possiamo contemplare?" Non è una domanda, è una strategia. Il Primo Emendamento – questo fastidioso ostacolo alla censura totale – viene trattato come un bug da correggere nel sistema operativo della società che immagina.

    La sua rivelazione prosegue senza filtri: "Credo che col tempo... vorremmo operare in un ambiente dove le persone siano veramente identificate... Dovremo sviluppare sistemi e comportamenti che ci permettano di essere più consapevoli riguardo a chi dice cosa, chi ha creato questo contenuto."

    Traduzione: nessuna voce anonima, nessun rifugio digitale, nessuna opinione senza un collare elettronico che ne tracci la provenienza. L'uomo che ha costruito un impero sul controllo dei sistemi operativi ora ambisce al controllo dell'ecosistema informativo globale.

    Non è un'evoluzione inaspettata per chi segue la traiettoria di Gates. Dal dominio dei computer personali alla manipolazione dei sistemi alimentari globali, dall'influenza sulla sanità mondiale all'ingegneria climatica – il pattern è sempre lo stesso: centralizzazione, controllo, abolizione delle alternative.
    L'ID digitale rappresenta semplicemente l'anello mancante – il dispositivo che salda definitivamente persona fisica e identità digitale, trasformando ogni espressione umana in dato tracciabile, classificabile, eventualmente censurabile.

    La tecnocrazia di cui Gates è portavoce non ha bisogno di campi di concentramento o plotoni d'esecuzione. Le bastano database, algoritmi e l'eliminazione sistematica dell'anonimato. Il dissenso non viene fucilato – viene semplicemente reso invisibile, relegato negli angoli più oscuri e inaccessibili della rete, privato di ossigeno mediatico.

    Chi ha seguito l'ascesa di questa élite tecnocratica riconosce i segnali. Gates non sta improvvisando – sta eseguendo il copione previsto, rivelando pubblicamente ciò che è stato pianificato nelle stanze dei bottoni della governance globale.
    L'ID digitale non è uno strumento isolato – è il fulcro di un ecosistema di controllo che include moneta digitale, credito sociale e biosorveglianza permanente. La "lotta alla disinformazione" è solo il pretesto nobile dietro cui nascondere l'obiettivo reale: la fine definitiva della privacy e dell'autonomia individuale.

    La domanda non è più "se" ma "quando" questo sistema verrà implementato. E soprattutto: quale resistenza siamo disposti a opporre?

    GATES SHOWS HIS CARDS: DIGITAL ID AS THE ULTIMATE WEAPON AGAINST FREE THOUGHT
    Here he goes again. The architect of global surveillance, the self-proclaimed prophet of health emergencies, the billionaire who whispers in the ear of governments, advances yet another piece of his technocratic project. Bill Gates – no longer hiding behind veils of philanthropy – articulates with disarming clarity the next phase: a digital identification system to stifle what he calls “misinformation.”

    “The United States is a complex case because of the First Amendment. What exceptions can we contemplate?” It’s not a question, it’s a strategy. The First Amendment – ​​that pesky obstacle to total censorship – is treated as a bug to be fixed in the operating system of the society he imagines.

    His revelation continues without filters: "I think that over time... we would like to operate in an environment where people are truly identified... We will have to develop systems and behaviors that allow us to be more aware of who says what, who created this content."

    Translation: no anonymous voice, no digital refuge, no opinion without an electronic collar that traces its origin. The man who built an empire on the control of operating systems now aspires to control the global information ecosystem.

    This is not an unexpected evolution for those who follow Gates' trajectory. From the domination of personal computers to the manipulation of global food systems, from influencing global health to climate engineering – the pattern is always the same: centralization, control, abolition of alternatives.

    The digital ID is simply the missing link – the device that definitively welds the physical person and digital identity, transforming every human expression into traceable, classifiable, possibly censorable data.

    The technocracy that Gates champions does not need concentration camps or firing squads. Databases, algorithms, and the systematic elimination of anonymity are enough. Dissent is not shot – it is simply made invisible, relegated to the darkest and most inaccessible corners of the internet, deprived of media oxygen.

    Anyone who has followed the rise of this technocratic elite recognizes the signs. Gates is not improvising – he is following the expected script, publicly revealing what has been planned in the control rooms of global governance.
    The digital ID is not an isolated tool – it is the centerpiece of an ecosystem of control that includes digital currency, social credit, and permanent biosurveillance. The "fight against disinformation" is just the noble pretext behind which to hide the real goal: the definitive end of privacy and individual autonomy.

    The question is no longer "if" but "when" this system will be implemented. And above all: what resistance are we willing to put up?

    t.me/lacivettabianca
    GATES SVELA LE CARTE: L'ID DIGITALE COME ARMA FINALE CONTRO IL LIBERO PENSIERO Eccolo di nuovo. L'architetto della sorveglianza globale, il profeta autoproclamato delle emergenze sanitarie, il miliardario che sussurra all'orecchio dei governi avanza l'ennesimo tassello del suo progetto tecnocratico. Bill Gates – che non si nasconde più dietro veli di filantropia – articola con disarmante chiarezza la prossima fase: un sistema di identificazione digitale per soffocare quella che lui chiama "disinformazione". "Gli Stati Uniti rappresentano un caso complesso a causa del Primo Emendamento. Quali eccezioni possiamo contemplare?" Non è una domanda, è una strategia. Il Primo Emendamento – questo fastidioso ostacolo alla censura totale – viene trattato come un bug da correggere nel sistema operativo della società che immagina. La sua rivelazione prosegue senza filtri: "Credo che col tempo... vorremmo operare in un ambiente dove le persone siano veramente identificate... Dovremo sviluppare sistemi e comportamenti che ci permettano di essere più consapevoli riguardo a chi dice cosa, chi ha creato questo contenuto." Traduzione: nessuna voce anonima, nessun rifugio digitale, nessuna opinione senza un collare elettronico che ne tracci la provenienza. L'uomo che ha costruito un impero sul controllo dei sistemi operativi ora ambisce al controllo dell'ecosistema informativo globale. Non è un'evoluzione inaspettata per chi segue la traiettoria di Gates. Dal dominio dei computer personali alla manipolazione dei sistemi alimentari globali, dall'influenza sulla sanità mondiale all'ingegneria climatica – il pattern è sempre lo stesso: centralizzazione, controllo, abolizione delle alternative. L'ID digitale rappresenta semplicemente l'anello mancante – il dispositivo che salda definitivamente persona fisica e identità digitale, trasformando ogni espressione umana in dato tracciabile, classificabile, eventualmente censurabile. La tecnocrazia di cui Gates è portavoce non ha bisogno di campi di concentramento o plotoni d'esecuzione. Le bastano database, algoritmi e l'eliminazione sistematica dell'anonimato. Il dissenso non viene fucilato – viene semplicemente reso invisibile, relegato negli angoli più oscuri e inaccessibili della rete, privato di ossigeno mediatico. Chi ha seguito l'ascesa di questa élite tecnocratica riconosce i segnali. Gates non sta improvvisando – sta eseguendo il copione previsto, rivelando pubblicamente ciò che è stato pianificato nelle stanze dei bottoni della governance globale. L'ID digitale non è uno strumento isolato – è il fulcro di un ecosistema di controllo che include moneta digitale, credito sociale e biosorveglianza permanente. La "lotta alla disinformazione" è solo il pretesto nobile dietro cui nascondere l'obiettivo reale: la fine definitiva della privacy e dell'autonomia individuale. La domanda non è più "se" ma "quando" questo sistema verrà implementato. E soprattutto: quale resistenza siamo disposti a opporre? GATES SHOWS HIS CARDS: DIGITAL ID AS THE ULTIMATE WEAPON AGAINST FREE THOUGHT Here he goes again. The architect of global surveillance, the self-proclaimed prophet of health emergencies, the billionaire who whispers in the ear of governments, advances yet another piece of his technocratic project. Bill Gates – no longer hiding behind veils of philanthropy – articulates with disarming clarity the next phase: a digital identification system to stifle what he calls “misinformation.” “The United States is a complex case because of the First Amendment. What exceptions can we contemplate?” It’s not a question, it’s a strategy. The First Amendment – ​​that pesky obstacle to total censorship – is treated as a bug to be fixed in the operating system of the society he imagines. His revelation continues without filters: "I think that over time... we would like to operate in an environment where people are truly identified... We will have to develop systems and behaviors that allow us to be more aware of who says what, who created this content." Translation: no anonymous voice, no digital refuge, no opinion without an electronic collar that traces its origin. The man who built an empire on the control of operating systems now aspires to control the global information ecosystem. This is not an unexpected evolution for those who follow Gates' trajectory. From the domination of personal computers to the manipulation of global food systems, from influencing global health to climate engineering – the pattern is always the same: centralization, control, abolition of alternatives. The digital ID is simply the missing link – the device that definitively welds the physical person and digital identity, transforming every human expression into traceable, classifiable, possibly censorable data. The technocracy that Gates champions does not need concentration camps or firing squads. Databases, algorithms, and the systematic elimination of anonymity are enough. Dissent is not shot – it is simply made invisible, relegated to the darkest and most inaccessible corners of the internet, deprived of media oxygen. Anyone who has followed the rise of this technocratic elite recognizes the signs. Gates is not improvising – he is following the expected script, publicly revealing what has been planned in the control rooms of global governance. The digital ID is not an isolated tool – it is the centerpiece of an ecosystem of control that includes digital currency, social credit, and permanent biosurveillance. The "fight against disinformation" is just the noble pretext behind which to hide the real goal: the definitive end of privacy and individual autonomy. The question is no longer "if" but "when" this system will be implemented. And above all: what resistance are we willing to put up? t.me/lacivettabianca
    Angry
    1
    0 Reacties 0 aandelen 4K Views 3
  • The global Respiratory Care Devices Market is poised for significant expansion over the coming decade, driven by rising prevalence of chronic respiratory diseases, technological advancements in respiratory monitoring, and a growing geriatric population. As respiratory conditions like COPD (Chronic Obstructive Pulmonary Disease), asthma, and sleep apnea become more widespread, the demand for both in-hospital and home respiratory monitoring solutions is set to escalate.

    The global respiratory care devices market size is expected to reach USD 44.96 billion by 2032, according to a new study by Polaris Market Research.

    Market Overview
    Respiratory care devices are used in the diagnosis, treatment, and monitoring of patients with respiratory conditions. These devices play a critical role in managing both acute and chronic respiratory diseases, offering solutions such as oxygen concentrators, nebulizers, inhalers, CPAP devices, and ventilator devices. With the advent of non-invasive and smart connected equipment, patient care is becoming more efficient, personalized, and accessible.

    The COVID-19 pandemic served as a catalyst for the global respiratory devices market, dramatically increasing the demand for mechanical ventilators and oxygen therapy equipment. Although the pandemic has waned, awareness of respiratory health has surged, fostering sustained demand for pulmonary therapy equipment across hospitals, clinics, and home care settings.

    Key Market Growth Drivers
    Surging Prevalence of Chronic Respiratory Diseases
    The increasing global burden of chronic respiratory diseases, particularly asthma and COPD, is a major factor driving market growth. According to the World Health Organization, over 300 million people suffer from asthma, and COPD is projected to become the third leading cause of death globally.

    Aging Global Population
    The global population aged 65 and above is growing rapidly. Older adults are more susceptible to respiratory conditions, necessitating the use of advanced monitoring and therapeutic devices. This demographic trend is expected to significantly boost market demand, particularly in developed economies.

    Technological Advancements and Smart Devices
    Integration of AI, IoT, and wireless technologies in respiratory care is revolutionizing the market. Devices now offer real-time monitoring, remote diagnostics, and enhanced patient compliance, making home respiratory monitoring increasingly feasible and effective.

    Post-COVID Healthcare Infrastructure Development
    The global healthcare system has witnessed heavy investments in critical care infrastructure post-COVID-19. Countries have bolstered their inventories of ventilator devices and oxygen supplies, creating a permanent demand baseline for emergency preparedness.

    Shift Toward Home-Based Care
    Patient preference for home care, cost-efficiency, and insurance support are encouraging the adoption of compact, portable respiratory solutions. Devices like portable oxygen concentrators and wearable respiratory monitors are seeing rising popularity.

    Market Challenges
    Despite strong growth potential, the respiratory care devices market faces several challenges:

    High Cost of Equipment: Advanced respiratory equipment, especially smart and portable devices, come at a high price, limiting accessibility in low-income regions.

    Reimbursement and Regulatory Hurdles: Inconsistent reimbursement policies across different countries and stringent regulatory requirements can hinder market expansion, particularly for new entrants.

    Device Maintenance and Calibration Issues: Regular maintenance, calibration, and user training are required for optimal functionality of respiratory devices, which may be challenging in remote or underserved areas.

    Lack of Skilled Healthcare Personnel: In many emerging markets, the shortage of trained professionals to operate complex devices like ventilators poses a major barrier.

    𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/respiratory-care-devices-market
    Regional Market Analysis
    North America
    North America remains the largest market for respiratory care devices, owing to its robust healthcare infrastructure, high awareness, and favorable reimbursement policies. The U.S. has witnessed significant growth in home respiratory monitoring due to its aging population and the rise of telehealth services.

    Europe
    Europe holds a substantial share, supported by high incidence rates of respiratory disorders, government healthcare funding, and technological adoption. Germany, the UK, and France lead the European market.

    Asia-Pacific
    The Asia-Pacific region is projected to experience the highest growth rate, driven by rising pollution levels, increasing smoking rates, and expanding healthcare access. Countries like China and India are investing heavily in healthcare modernization and local manufacturing of pulmonary therapy equipment.

    Latin America and Middle East & Africa
    These regions are gradually developing their healthcare systems. Brazil, South Africa, and Saudi Arabia are showing increasing demand for ventilator devices and diagnostic tools due to growing awareness and government initiatives.

    Key Companies in the Respiratory Care Devices Market
    Several global and regional players dominate the respiratory care devices market. Key companies are focusing on product innovation, strategic partnerships, and geographic expansion to strengthen their positions.

    Philips Respironics (Koninklijke Philips N.V.)
    A major player in sleep and respiratory care, known for its CPAP machines, oxygen concentrators, and home respiratory monitoring solutions.

    ResMed Inc.
    Specializes in cloud-connected devices for sleep apnea and other chronic respiratory diseases. Its cloud-based platform helps patients and providers track and manage respiratory health remotely.

    Medtronic plc
    Offers a wide range of respiratory support products including mechanical ventilators and monitoring systems. Strong presence in hospitals and critical care settings.

    Fisher & Paykel Healthcare
    Known for innovative respiratory humidification and ventilation products, especially in neonatal and adult intensive care.

    Drägerwerk AG & Co. KGaA
    A German company with a strong foothold in critical care, especially mechanical ventilators and anesthesia workstations.

    GE Healthcare
    Provides advanced respiratory diagnostic imaging and ventilator support technologies. Collaborating with AI firms to enhance device intelligence.

    Vyaire Medical Inc.
    A specialist in respiratory diagnostics and ventilation solutions, especially popular among clinics and home care providers.

    Future Outlook
    The future of the respiratory care devices market looks promising with the continued focus on non-invasive, intelligent, and personalized care. The rise of pulmonary therapy equipment that integrates wearable technology, remote access, and data analytics will significantly transform the way respiratory conditions are managed globally.

    Investments in R&D, coupled with strong collaborations between med-tech firms and healthcare providers, are expected to yield groundbreaking innovations in the coming years. Meanwhile, the adoption of green technologies and sustainability practices in device manufacturing is gaining traction to address environmental concerns.

    Conclusion
    In conclusion, the global respiratory care devices market is entering a transformative phase, fueled by medical necessity, technological innovation, and changing healthcare delivery models. With robust growth across both developed and emerging markets, the sector offers ample opportunities for investors, manufacturers, and healthcare providers alike.

    As chronic respiratory illnesses continue to burden health systems worldwide, the emphasis on early diagnosis, personalized therapy, and accessible care will remain at the heart of respiratory device development.

    More Trending Latest Reports By Polaris Market Research:

    Voluntary Carbon Credit Market

    Precision Swine Farming Market

    D-Dimer Testing Market

    Flame Retardants Market

    Wax Melts Market

    Europe Facial Injectables Market

    Reverse Osmosis (RO) Membrane Market

    Electrolytic Manganese Dioxide Market

    Cyber Security Market
    The global Respiratory Care Devices Market is poised for significant expansion over the coming decade, driven by rising prevalence of chronic respiratory diseases, technological advancements in respiratory monitoring, and a growing geriatric population. As respiratory conditions like COPD (Chronic Obstructive Pulmonary Disease), asthma, and sleep apnea become more widespread, the demand for both in-hospital and home respiratory monitoring solutions is set to escalate. The global respiratory care devices market size is expected to reach USD 44.96 billion by 2032, according to a new study by Polaris Market Research. 🌍 Market Overview Respiratory care devices are used in the diagnosis, treatment, and monitoring of patients with respiratory conditions. These devices play a critical role in managing both acute and chronic respiratory diseases, offering solutions such as oxygen concentrators, nebulizers, inhalers, CPAP devices, and ventilator devices. With the advent of non-invasive and smart connected equipment, patient care is becoming more efficient, personalized, and accessible. The COVID-19 pandemic served as a catalyst for the global respiratory devices market, dramatically increasing the demand for mechanical ventilators and oxygen therapy equipment. Although the pandemic has waned, awareness of respiratory health has surged, fostering sustained demand for pulmonary therapy equipment across hospitals, clinics, and home care settings. 🚀 Key Market Growth Drivers Surging Prevalence of Chronic Respiratory Diseases The increasing global burden of chronic respiratory diseases, particularly asthma and COPD, is a major factor driving market growth. According to the World Health Organization, over 300 million people suffer from asthma, and COPD is projected to become the third leading cause of death globally. Aging Global Population The global population aged 65 and above is growing rapidly. Older adults are more susceptible to respiratory conditions, necessitating the use of advanced monitoring and therapeutic devices. This demographic trend is expected to significantly boost market demand, particularly in developed economies. Technological Advancements and Smart Devices Integration of AI, IoT, and wireless technologies in respiratory care is revolutionizing the market. Devices now offer real-time monitoring, remote diagnostics, and enhanced patient compliance, making home respiratory monitoring increasingly feasible and effective. Post-COVID Healthcare Infrastructure Development The global healthcare system has witnessed heavy investments in critical care infrastructure post-COVID-19. Countries have bolstered their inventories of ventilator devices and oxygen supplies, creating a permanent demand baseline for emergency preparedness. Shift Toward Home-Based Care Patient preference for home care, cost-efficiency, and insurance support are encouraging the adoption of compact, portable respiratory solutions. Devices like portable oxygen concentrators and wearable respiratory monitors are seeing rising popularity. ⚠️ Market Challenges Despite strong growth potential, the respiratory care devices market faces several challenges: High Cost of Equipment: Advanced respiratory equipment, especially smart and portable devices, come at a high price, limiting accessibility in low-income regions. Reimbursement and Regulatory Hurdles: Inconsistent reimbursement policies across different countries and stringent regulatory requirements can hinder market expansion, particularly for new entrants. Device Maintenance and Calibration Issues: Regular maintenance, calibration, and user training are required for optimal functionality of respiratory devices, which may be challenging in remote or underserved areas. Lack of Skilled Healthcare Personnel: In many emerging markets, the shortage of trained professionals to operate complex devices like ventilators poses a major barrier. 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/respiratory-care-devices-market 🌐 Regional Market Analysis North America North America remains the largest market for respiratory care devices, owing to its robust healthcare infrastructure, high awareness, and favorable reimbursement policies. The U.S. has witnessed significant growth in home respiratory monitoring due to its aging population and the rise of telehealth services. Europe Europe holds a substantial share, supported by high incidence rates of respiratory disorders, government healthcare funding, and technological adoption. Germany, the UK, and France lead the European market. Asia-Pacific The Asia-Pacific region is projected to experience the highest growth rate, driven by rising pollution levels, increasing smoking rates, and expanding healthcare access. Countries like China and India are investing heavily in healthcare modernization and local manufacturing of pulmonary therapy equipment. Latin America and Middle East & Africa These regions are gradually developing their healthcare systems. Brazil, South Africa, and Saudi Arabia are showing increasing demand for ventilator devices and diagnostic tools due to growing awareness and government initiatives. 🏢 Key Companies in the Respiratory Care Devices Market Several global and regional players dominate the respiratory care devices market. Key companies are focusing on product innovation, strategic partnerships, and geographic expansion to strengthen their positions. Philips Respironics (Koninklijke Philips N.V.) A major player in sleep and respiratory care, known for its CPAP machines, oxygen concentrators, and home respiratory monitoring solutions. ResMed Inc. Specializes in cloud-connected devices for sleep apnea and other chronic respiratory diseases. Its cloud-based platform helps patients and providers track and manage respiratory health remotely. Medtronic plc Offers a wide range of respiratory support products including mechanical ventilators and monitoring systems. Strong presence in hospitals and critical care settings. Fisher & Paykel Healthcare Known for innovative respiratory humidification and ventilation products, especially in neonatal and adult intensive care. Drägerwerk AG & Co. KGaA A German company with a strong foothold in critical care, especially mechanical ventilators and anesthesia workstations. GE Healthcare Provides advanced respiratory diagnostic imaging and ventilator support technologies. Collaborating with AI firms to enhance device intelligence. Vyaire Medical Inc. A specialist in respiratory diagnostics and ventilation solutions, especially popular among clinics and home care providers. 🔮 Future Outlook The future of the respiratory care devices market looks promising with the continued focus on non-invasive, intelligent, and personalized care. The rise of pulmonary therapy equipment that integrates wearable technology, remote access, and data analytics will significantly transform the way respiratory conditions are managed globally. Investments in R&D, coupled with strong collaborations between med-tech firms and healthcare providers, are expected to yield groundbreaking innovations in the coming years. Meanwhile, the adoption of green technologies and sustainability practices in device manufacturing is gaining traction to address environmental concerns. 📌 Conclusion In conclusion, the global respiratory care devices market is entering a transformative phase, fueled by medical necessity, technological innovation, and changing healthcare delivery models. With robust growth across both developed and emerging markets, the sector offers ample opportunities for investors, manufacturers, and healthcare providers alike. As chronic respiratory illnesses continue to burden health systems worldwide, the emphasis on early diagnosis, personalized therapy, and accessible care will remain at the heart of respiratory device development. More Trending Latest Reports By Polaris Market Research: Voluntary Carbon Credit Market Precision Swine Farming Market D-Dimer Testing Market Flame Retardants Market Wax Melts Market Europe Facial Injectables Market Reverse Osmosis (RO) Membrane Market Electrolytic Manganese Dioxide Market Cyber Security Market
    WWW.POLARISMARKETRESEARCH.COM
    Respiratory Care Devices Market Size ,Trends, Growth, 2032
    Respiratory Care Devices Market size and share predicted to reach USD 44.96 billion by 2032, with a CAGR of 8.8% CAGR.
    0 Reacties 0 aandelen 3K Views
  • "Il virus Covid19, dobbiamo dirlo sempre con più forza non ha ucciso nessuno. Nessuno, neanche una persona che non avesse delle problematiche legate al sistema immunitario oppure a patologie pregresse. Noi pensate quanto è importante diceva giustamente il professore iniziamo a togliere anche un altro degli alibi. Okay, la Cina ci ha dato dei dati falsi, però ci ha dato delle indicazioni precise. Le indicazioni ce la date e il Governo italiano e tutte le istituzioni Istituto superiore di sanità non l'ha assolutamente ascoltate perché è importante dire il discorso delle delle autopsie perché tutto nasce da lì.
    Lo snodo è tutto lì cioè noi abbiamo sbagliato il protocollo.
    Vi faccio un esempio banalissimo quando noi diciamo diceva Giorgianni strage di Stato assassini dolosi in alcuni casi anche dolosi. Perché abbiamo ucciso le persone.

    Voi immaginate che oggi prendiamo dei diabetici e sbagliamo completamente terapia. Da stamattina noi iniziamo a dare lo zucchero a tutti i diabetici. Stasera le terapie intensive saranno piene di persone. È questo il problema. Noi abbiamo eliminato completamente i farmaci che oggi portano da guarigione immediata. L'eparina he gli antinfiammatori la idrossi-clorochina, addirittura demonizzata da un giornale che aveva una reputazione ma anche lui l'ha persa: The Lancet.
    E abbiamo invece dato tutto il contrario. Abbiamo dato questa ventilazione profonda. Io non so se voi vi rendete conto cos'è. La ventilazione profonda noi abbiamo bruciato i polmoni perché l'ossigeno che noi buttavamo nell'apparato respiratorio per la trombo embolia polmonare non poteva essere neanche utilizzato..."
    ...
    Così Pasquale Bacco il "medico pentito"

    Thus spoke Pasquale Bacco, the "repentant doctor," during the parliamentary hearing.
    **MAXIMUM DISSEMINATION!**

    "The Covid19 virus, we must say it more and more forcefully, did not kill anyone. Nobody, not even a person who did not have problems related to the immune system or previous pathologies. We think how important it is rightly said the professor begins to remove another of the alibis. Okay, China gave us false data, but it gave us precise directions. The indications are given to us and the Italian Government and all the institutions of the Higher Institute of Health have absolutely not listened to it because it is important to say the speech of the autopsies because everything is born from there. The joint is all there that is, we made the wrong protocol. I give you a very trivial example when we say Giorgianni said massacre of state malicious killers in some cases even malicious. Because we killed people. You imagine that today we take diabetics and completely miss therapy. From this morning we begin to give sugar to all diabetics. Intensive care will be full of people tonight. This is the problem. We have completely eliminated the drugs that today lead to immediate recovery. Heparin he the anti-inflammatory hydroxy-chloroquine, even demonized by a newspaper that had a reputation but he also lost it: The Lancet. And instead we have given quite the opposite. We have given this deep ventilation. I don't know if you realize what it is. Deep ventilation we burned the lungs because the oxygen we threw into the respiratory system for the pulmonary embolism thrombus could not even be used ... "
    "Il virus Covid19, dobbiamo dirlo sempre con più forza non ha ucciso nessuno. Nessuno, neanche una persona che non avesse delle problematiche legate al sistema immunitario oppure a patologie pregresse. Noi pensate quanto è importante diceva giustamente il professore iniziamo a togliere anche un altro degli alibi. Okay, la Cina ci ha dato dei dati falsi, però ci ha dato delle indicazioni precise. Le indicazioni ce la date e il Governo italiano e tutte le istituzioni Istituto superiore di sanità non l'ha assolutamente ascoltate perché è importante dire il discorso delle delle autopsie perché tutto nasce da lì. Lo snodo è tutto lì cioè noi abbiamo sbagliato il protocollo. Vi faccio un esempio banalissimo quando noi diciamo diceva Giorgianni strage di Stato assassini dolosi in alcuni casi anche dolosi. Perché abbiamo ucciso le persone. Voi immaginate che oggi prendiamo dei diabetici e sbagliamo completamente terapia. Da stamattina noi iniziamo a dare lo zucchero a tutti i diabetici. Stasera le terapie intensive saranno piene di persone. È questo il problema. Noi abbiamo eliminato completamente i farmaci che oggi portano da guarigione immediata. L'eparina he gli antinfiammatori la idrossi-clorochina, addirittura demonizzata da un giornale che aveva una reputazione ma anche lui l'ha persa: The Lancet. E abbiamo invece dato tutto il contrario. Abbiamo dato questa ventilazione profonda. Io non so se voi vi rendete conto cos'è. La ventilazione profonda noi abbiamo bruciato i polmoni perché l'ossigeno che noi buttavamo nell'apparato respiratorio per la trombo embolia polmonare non poteva essere neanche utilizzato..." ... Così Pasquale Bacco il "medico pentito" Thus spoke Pasquale Bacco, the "repentant doctor," during the parliamentary hearing. **MAXIMUM DISSEMINATION!** "The Covid19 virus, we must say it more and more forcefully, did not kill anyone. Nobody, not even a person who did not have problems related to the immune system or previous pathologies. We think how important it is rightly said the professor begins to remove another of the alibis. Okay, China gave us false data, but it gave us precise directions. The indications are given to us and the Italian Government and all the institutions of the Higher Institute of Health have absolutely not listened to it because it is important to say the speech of the autopsies because everything is born from there. The joint is all there that is, we made the wrong protocol. I give you a very trivial example when we say Giorgianni said massacre of state malicious killers in some cases even malicious. Because we killed people. You imagine that today we take diabetics and completely miss therapy. From this morning we begin to give sugar to all diabetics. Intensive care will be full of people tonight. This is the problem. We have completely eliminated the drugs that today lead to immediate recovery. Heparin he the anti-inflammatory hydroxy-chloroquine, even demonized by a newspaper that had a reputation but he also lost it: The Lancet. And instead we have given quite the opposite. We have given this deep ventilation. I don't know if you realize what it is. Deep ventilation we burned the lungs because the oxygen we threw into the respiratory system for the pulmonary embolism thrombus could not even be used ... "
    Angry
    1
    0 Reacties 0 aandelen 6K Views 8
  • https://www.databridgemarketresearch.com/jp/reports/global-oxygen-scavenger-masterbatch-market
    https://www.databridgemarketresearch.com/jp/reports/global-oxygen-scavenger-masterbatch-market
    グローバル酸素吸収マスターバッチ市場レポート-業界動向および2028年までの予測| Data Bridge Market Research
    グローバル酸素吸収剤マスターバッチ市場、製品タイプ(無機製品、有機製品)、用途(フレキシブル包装、硬質包装)、エンドユーザー(鶏肉および魚介類、肉、乳製品、果物および野菜、お菓子、アルコール飲料、その他)、タイプ(PETマスターバッチ、PPマスターバッチ、PEマスターバッチ)、国(米国、カナダ、メキシコ、ブラジル、アルゼンチン、南アメリカのその他の地域、ドイツ、フランス、イタリア、英国、ベルギー、スペイン、ロシア、トルコ、オランダ、スイス、ヨーロッパのその他の地域、日本、中国、インド、韓国、豪州、シンガポール、マレーシア、タイ、インドネシア、フィリピン、アジア太平洋地域のその他の地域、UAE、サウジアラビア、エジプト、南アフリカ、イスラエル、その他の中東とアフリカ)業界動向と2028年までの予測
    0 Reacties 0 aandelen 284 Views
  • https://www.databridgemarketresearch.com/jp/reports/global-oxygen-conservers-market
    https://www.databridgemarketresearch.com/jp/reports/global-oxygen-conservers-market
    酸素コンサーバー市場規模、展望&2030年までの将来の展望
    2022年の酸素コンサーバー市場規模は1,226.67百万ドルであり、2030年に2,823.24百万ドルを超え、予測期間中のCAGRは11.1%に達する。
    0 Reacties 0 aandelen 145 Views
  • https://www.databridgemarketresearch.com/pt/reports/global-extracorporeal-membrane-oxygenation-machine-market
    https://www.databridgemarketresearch.com/pt/reports/global-extracorporeal-membrane-oxygenation-machine-market
    Tamanho E Crescimento Do Mercado De Máquinas De Oxigenação Por Membrana Extracorpórea Até 2029
    O Mercado de Máquinas de Oxigenação por Membrana Extracorpórea apresentará uma CAGR de cerca de 4,65% para o período de previsão e América do Norte e Europa são as regiões dominantes.
    0 Reacties 0 aandelen 222 Views
  • https://www.databridgemarketresearch.com/es/reports/global-extracorporeal-membrane-oxygenation-machine-market
    https://www.databridgemarketresearch.com/es/reports/global-extracorporeal-membrane-oxygenation-machine-market
    Tamaño Y Crecimiento Del Mercado De Máquinas De Oxigenación Por Membrana Extracorpórea Para 2029
    El mercado de máquinas de oxigenación por membrana extracorpórea exhibirá una tasa de crecimiento anual compuesta de alrededor del 4.65% para el período de pronóstico, y América del Norte y Europa son las regiones dominantes.
    0 Reacties 0 aandelen 239 Views
  • https://www.databridgemarketresearch.com/jp/reports/global-extracorporeal-membrane-oxygenation-machine-market
    https://www.databridgemarketresearch.com/jp/reports/global-extracorporeal-membrane-oxygenation-machine-market
    2029年までの体外膜酸素化装置の市場規模と成長
    人工心肺マシン市場は予測期間に約4.65%のCAGRを示し、北アメリカとヨーロッパが支配的な地域である。
    0 Reacties 0 aandelen 285 Views
  • https://www.databridgemarketresearch.com/ko/reports/global-extracorporeal-membrane-oxygenation-machine-market
    https://www.databridgemarketresearch.com/ko/reports/global-extracorporeal-membrane-oxygenation-machine-market
    2029년까지의 체외막 산소화 기계 시장 규모 및 성장
    체외막산소투석기계 시장은 예측 기간 동안 약 4.65%의 CAGR을 보일 것이며 북미 및 유럽이 선도하는 지역입니다.
    0 Reacties 0 aandelen 196 Views
  • https://www.databridgemarketresearch.com/es/reports/global-extracorporeal-membrane-oxygenation-machine-market
    https://www.databridgemarketresearch.com/es/reports/global-extracorporeal-membrane-oxygenation-machine-market
    Tamaño Y Crecimiento Del Mercado De Máquinas De Oxigenación Por Membrana Extracorpórea Para 2029
    El mercado de máquinas de oxigenación por membrana extracorpórea exhibirá una tasa de crecimiento anual compuesta de alrededor del 4.65% para el período de pronóstico, y América del Norte y Europa son las regiones dominantes.
    0 Reacties 0 aandelen 128 Views
Zoekresultaten